Artelo Biosciences Stock News

SOLANA BEACH, Calif., May 16, 2022 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. “Artelo” or the “Company”) (NASDAQ: ARTL), a clinical stage pharmaceutical company developing therapeutics that

SOLANA BEACH, CA / ACCESSWIRE / May 13, 2022 / Artelo Biosciences, Inc. "Artelo" or the "Company") (NASDAQ:ARTL), a clinical stage pharmaceutical company developing therapeutics that modulate lipid-si

Solana Beach, California--(Newsfile Corp. - April 26, 2022) - Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage pharmaceutical company developing therapeutics that modulate lipid-signaling pat

Penny stocks under $1 to watch right now. The post Best Penny Stocks To Buy Now?

Artelo Biosciences Inc. (NASDAQ:ARTL) shares, rose in value on Wednesday, 03/09/22, with the stock price up by 4.21% to the previous day’s close as strong demand from buyers drove the stock to $0.43. Actively observing the price movement in the last trading, the stock closed the session at $0.41, falling within a range of $0.4105 … Artelo Biosciences Inc. (NASDAQ: ARTL) Surged 4.21%, So What Now? Read More »

Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM ) rose 420% to $7.90 in pre-market trading. Sunshine Biopharma, last month, priced its 1.88 million unit uplisting to Nasdaq at $4.25 per unit. TC Biopharm (Holdings) Plc (NASDAQ: TCBP ) rose 90% to $1.84 in pre-market trading. TC BioPharm, on Tuesday, disclosed positive Phase 1b/2a data in late-stage Acute Myeloid Leukemia patients treated with allogeneic gamma delta T cells. Direct Digital Holdings, Inc. (NASDAQ: DRCT ) rose 63.3% to $1.96 in pre-market trading. Benchmark initiated coverage on Direct Digital with a Buy rating and announced a price target of $8. ECMOHO Limited (NASDAQ: MOHO ) shares rose 35.9% to $0.2901 in pre-market trading. Ecoark Holdings, Inc. (NASDAQ: ZEST ) rose 33.1% to $4.06 in pre-market trading after the company reported successful drilling of Louisiana oil well. Artelo Biosciences, Inc. (NASDAQ: ARTL ) rose 25.7% to $0.5170 in pre-market trading. Artelo Biosciences, last week, received a Notice of Allowance for method-of-use patent in the United States for ART12.11, a proprietary cocrystal of cannabidiol.

Over 10 million people are stricken by cancer each year, with as much as 60% suffering from loss of appetite or anorexia and wasting disease or cachexia.

Artelo Biosciences Inc (ARTL) shares closed 3.3% lower than its previous 52 week low, giving the company a market cap of $20M. The stock is currently down 8.4% year-to-date, down 50.7% over the past 12 months, and down 89.8% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 rose 0.6%. Trading Activity Trading volume this week was 4.2% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 2.1. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Consumer Discretionary industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 178.5% The company's stock price performance over the past 12 months lags the peer average by 66.0% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Artelo Biosciences (ARTL): FQ1 GAAP EPS of -$0.08 misses by $0.02.As of November 30, 2021, the company had ~$26.4M in cash and marketable securities, compared to $10.07M as of August

Artelo Biosciences Inc (ARTL) shares closed 6.1% lower than its previous 52 week low, giving the company a market cap of $21M. The stock is currently down 3.7% year-to-date, down 52.4% over the past 12 months, and down 89.2% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%. Trading Activity Trading volume this week was 32.3% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 2.1. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Consumer Discretionary industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 131.3% The company's stock price performance over the past 12 months lags the peer average by 74.3% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Artelo CEO also providing corporate outlook for 2022 at the H.C. Wainwright Conference Artelo CEO also providing corporate outlook for 2022 at the H.C. Wainwright Conference

Artelo Biosciences Inc (ARTL) shares closed today at 1.3% above its 52 week low of $0.51, giving the company a market cap of $21M. The stock is currently up 0.2% year-to-date, down 39.6% over the past 12 months, and down 88.8% over the past five years. This week, the Dow Jones Industrial Average fell 0.2%, and the S&P 500 fell 1.9%. Trading Activity Trading volume this week was 35.7% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 2.1. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Consumer Discretionary industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -119.5% The company's stock price performance over the past 12 months lags the peer average by 29.8% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Here is how Artelo Biosciences, Inc. (ARTL) and Avalo Therapeutics, Inc. (AVTX) have performed compared to their sector so far this year.

Artelo Biosciences Inc (ARTL) shares closed today at 1.9% above its 52 week low of $0.51, giving the company a market cap of $23M. The stock is currently up 6.4% year-to-date, down 33.8% over the past 12 months, and down 88.1% over the past five years. This week, the Dow Jones Industrial Average rose 1.1%, and the S&P 500 rose 0.1%. Trading Activity Trading volume this week was 42.2% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 2.2. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Consumer Discretionary industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 443.7% The company's stock price performance over the past 12 months lags the peer average by 13.0% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.